---
title: ProBio vs WuXi AppTec
slug_a: probio
slug_b: wuxiapptec
site: cro
review_signal_gate: closed
canonical_path: /compare/probio/wuxiapptec
generated_by: BioBM Editorial AI
---

# ProBio vs WuXi AppTec

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

ProBio (probio) is listed for both. ProBio is a leading global CDMO subsidiary of GenScript Biotech Corporation, providing end-to-end services for biologics and cell & gene therapy (CGT) from drug discovery through commercialization.

Services: 7. Modalities: 7. Indications: 1. Locations: 6. Certifications: 3. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (7).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

WuXi AppTec (wuxiapptec) is listed for cro. Global CRDMO platform providing integrated end-to-end contract research, development, and manufacturing services across discovery, preclinical, clinical, and commercial phases for small molecules, peptides, oligonucleotides, and biologics across 30+ countries.

Services: 41. Modalities: 10. Indications: 14. Locations: 2. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (41).

Review summary: Review summary withheld until site-level review gate opens.